✦ LIBER ✦

PID2: PHARMACOECONOMIC EVALUATION OF IMMUNOPROPHYLAXIS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN HIGH-RISK INFANTS

✍ Scribed by J Doshi; S Kamal-Bahl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Respiratory syncytial virus infection an

✍ Srinivas Bolisetty; Gavin Wheaton; Anne B. Chang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Palivizumab, a Humanized Respiratory Syn

📂 Article 📅 1998 🏛 American Academy of Pediatrics 🌐 English ⚖ 340 KB

PIN35 COST-EFFECTIVENESS ANALYSIS OF PAL

✍ S Ikeda; M Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

EFFICACY OF PROPHYLAXIS AGAINST RESPIRAT

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Prevalence of Respiratory Syncytial Viru

✍ Leonard R. Krilov; Debra L. Palazzi; Ancilla W. Fernandes; Robert W. Klein; Part 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

The role of RSV neutralizing antibodies

✍ Jessie R. Groothuis 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 623 KB